[LS-53] Luncheon Seminar 53　Complement and neuroimmune diseases - Why is complement control necessary now?-

[LS-53-1] Considering treatments that do not cause waves of MG symptoms - The need for complement inhibitors -

Akiyuki Uzawa (Department of Neurology, Graduate School of Medicine, Chiba University, Japan)